{"title":"Apathy Associated with Alzheimer's Disease.","authors":"Dan Wu, Bo Zhang, Yajuan Chang, Shuming Huang","doi":"10.2174/0115672050350970241216072400","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction/objective: </strong>Apathy is a multidimensional and complex disease that is the primary neuropsychiatric symptom among those diagnosed with Alzheimer's disease (AD). Yet, apathy in AD is sometimes underestimated.</p><p><strong>Methods: </strong>A systematic literature review was conducted using databases such as PubMed, Scopus, and Web of Science. The search utilized specific keywords related to apathy and Alzheimer's disease (e.g., \"apathy,\" \"Alzheimer's disease,\" \"neuropsychiatric symptoms,\" \"front-striatal circuitry\"). The studies were selected based on pre-defined criteria, including publication date (within the last 10 years), peer-reviewed status, and relevance to neurobiological, neurochemical, and behavioral aspects of apathy in AD. The articles were screened through title and abstract reviews, followed by full-text evaluations to ensure they met the inclusion criteria, such as relevance to apathy in Alzheimer's patients, study design rigor, and methodological quality.</p><p><strong>Results: </strong>Some research on the behavioral and neurobiological characteristics of apathy in AD points to the role of the front-striatal circuitry, particularly the anterior cingulate cortex (ACC). In addition, we reviewed the neurochemical, neuropsychological, and neuropathological characteristics believed to be associated with apathy symptoms.</p><p><strong>Conclusion: </strong>The findings indicate that understanding the intricate neurobiological underpinnings of apathy in AD is crucial for developing targeted interventions. Our analysis suggests that a multimodal approach, incorporating both pharmacological and personalized non-pharmacological strategies, could enhance therapeutic efficacy and improve patient outcomes. This highlights the need for future research to explore these combined treatment modalities and their potential to alleviate apathy in AD patients.</p>","PeriodicalId":94309,"journal":{"name":"Current Alzheimer research","volume":" ","pages":"527-537"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Alzheimer research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115672050350970241216072400","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction/objective: Apathy is a multidimensional and complex disease that is the primary neuropsychiatric symptom among those diagnosed with Alzheimer's disease (AD). Yet, apathy in AD is sometimes underestimated.
Methods: A systematic literature review was conducted using databases such as PubMed, Scopus, and Web of Science. The search utilized specific keywords related to apathy and Alzheimer's disease (e.g., "apathy," "Alzheimer's disease," "neuropsychiatric symptoms," "front-striatal circuitry"). The studies were selected based on pre-defined criteria, including publication date (within the last 10 years), peer-reviewed status, and relevance to neurobiological, neurochemical, and behavioral aspects of apathy in AD. The articles were screened through title and abstract reviews, followed by full-text evaluations to ensure they met the inclusion criteria, such as relevance to apathy in Alzheimer's patients, study design rigor, and methodological quality.
Results: Some research on the behavioral and neurobiological characteristics of apathy in AD points to the role of the front-striatal circuitry, particularly the anterior cingulate cortex (ACC). In addition, we reviewed the neurochemical, neuropsychological, and neuropathological characteristics believed to be associated with apathy symptoms.
Conclusion: The findings indicate that understanding the intricate neurobiological underpinnings of apathy in AD is crucial for developing targeted interventions. Our analysis suggests that a multimodal approach, incorporating both pharmacological and personalized non-pharmacological strategies, could enhance therapeutic efficacy and improve patient outcomes. This highlights the need for future research to explore these combined treatment modalities and their potential to alleviate apathy in AD patients.
简介/目的:冷漠是一种多维的复杂疾病,是阿尔茨海默病(AD)患者的主要神经精神症状。然而,阿尔茨海默病的冷漠程度有时被低估了。方法:采用PubMed、Scopus、Web of Science等数据库进行系统文献综述。搜索使用了与冷漠和阿尔茨海默病相关的特定关键词(例如,“冷漠”、“阿尔茨海默病”、“神经精神症状”、“前纹状体回路”)。这些研究是根据预先定义的标准选择的,包括发表日期(最近10年内)、同行评议状态以及与阿尔茨海默病中冷漠的神经生物学、神经化学和行为方面的相关性。文章通过标题和摘要综述进行筛选,随后进行全文评估,以确保它们符合纳入标准,例如与阿尔茨海默病患者冷漠的相关性、研究设计的严谨性和方法质量。结果:一些关于阿尔茨海默病中冷漠的行为和神经生物学特征的研究指出了前纹状体回路,特别是前扣带皮层(ACC)的作用。此外,我们回顾了被认为与冷漠症状相关的神经化学、神经心理学和神经病理学特征。结论:研究结果表明,了解阿尔茨海默病中冷漠的复杂神经生物学基础对于制定有针对性的干预措施至关重要。我们的分析表明,结合药物和个性化非药物策略的多模式方法可以提高治疗效果并改善患者预后。这突出了未来研究探索这些联合治疗方式及其缓解AD患者冷漠的潜力的必要性。